In this issue:
- Polypill for secondary cardiovascular prevention
- Dapagliflozin in heart failure with reduced ejection fraction
- Screening for prediabetes and type 2 diabetes in children and adolescents
- Artificial sweeteners and risk of cardiovascular diseases
- Effect of statin therapy on muscle symptoms
- Autoimmune diseases and cardiovascular risk
- Syncope and risk of subsequent motor vehicle crash
- Myocardial infarct, stroke and pulmonary embolism after COVID-19 vaccination
- Sublingual ketamine for chronic non-malignant pain management
- Prevalence of scabies in Auckland pre-schools
- Acupuncture, moxibustion and cupping for post-herpetic neuralgia
- Prevention of COVID-19 and acute respiratory infections with cod liver oil
Please login below to download this issue (PDF)